SALT LAKE CITY, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and ...
Myriad Genetics , Inc. (NASDAQ:MYGN) stock has reached a new 52-week low, touching down at $12.16, as the company faces a challenging market environment. According to InvestingPro data, technical ...
Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most prevalent and deadliest forms of ovarian cancer. Their work is published in ...
Researchers at deCODE genetics have developed a groundbreaking DNA map, revealing the intricate process of genetic recombination during reproduction. This map highlights areas of DNA that undergo ...
La Rosa Holdings Corp. (NASDAQ: LRHC) ("La Rosa” or the "Company”), a holding company for six agent-centric, technology-integrated, cloud-based, multi-service real estate segments, today announced ...
The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...
The test employs a combination of tumour-agnostic next-generation sequencing and personalised tumour-informed droplet PCR ...